The PurpleLab^® Resource Center

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

Why Real-World Evidence Matters Beyond Clinical Trials Market access has never been more complex than it is right now. In a world where payers are tightening the purse strings and every therapeutic area feels like a battleground, just getting a therapy onto formulary, or getting a diagnostic test approved isn’t enough. You need to prove…

Discover how a clinical trial overcame patient enrollment challenges by addressing PI expertise misalignment and leveraging data-driven referral tools.

Clinical trials tell you a lot – but they don’t tell you everything you need to know to truly compete in today’s saturated pharma market. Sure, they’re the gold standard for proving safety and efficacy. But once a drug hits the real world, all bets are off. Patients don’t follow protocols. Even providers don’t always…